Insider tradingForm 4
MapLight Therapeutics, Inc. (MPLT) Insider Trading
8 open-market trades reported since Aug 18, 2026: 1 purchases worth $50.1M and 7 sales worth $1.26M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Christopher A. Kroeger | CEO | 0 | $0 | 1 | $595K |
| Erin Pennock Foff | Chief Medical Officer | 0 | $0 | 1 | $124K |
| Anatol Kreitzer | Chief Discovery Officer | 0 | $0 | 1 | $96K |
| James Woodruff Lillie | Chief Scientific Officer | 0 | $0 | 1 | $93K |
| Jonathan Gillis | CFO | 0 | $0 | 1 | $82K |
| Kristopher Hanson | General Counsel | 0 | $0 | 2 | $266K |
| Catalyst4, Inc. | 10% owner | 1 | $50.1M | 0 | $0 |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 16 | Christopher A. KroegerCEO | ▼ SELL | $595K | |
| Oct 16 | Erin Pennock FoffChief Medical Officer | ▼ SELL | $124K | |
| Oct 16 | Anatol KreitzerChief Discovery Officer | ▼ SELL | $96K | |
| Oct 16 | James Woodruff LillieChief Scientific Officer | ▼ SELL | $93K | |
| Oct 16 | Jonathan GillisCFO | ▼ SELL | $82K | |
| Oct 16 | Kristopher HansonGeneral Counsel | ▼ SELL | $73K | |
| Sep 18 | Kristopher HansonGeneral Counsel | ▼ SELL10b5-1 | $193K | |
| Aug 18 | Catalyst4, Inc.10% owner | ▲ BUY | $50.1M |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings